Expression Of Immune Checkpoints PD-L1, PD-L2, PD-1 and CTLA4 Predict For Prognosis and Resistance To Hypomethylating Agents (HMAs) In Myelodysplastic Syndromes (MDS)

Autor: Yang, Hui *, Bueso-Ramos, Carlos E., DiNardo, Courtney D., Estecio, Marcos R *, Davanlou, Masoud *, Geng, Qi-Rong *, Fang, Zhihong *, Nguyen, Martin *, Pierce, Sherry *, Wei, Yue, Parmar, Simrit, Cortes, Jorge E., Kantarjian, Hagop M., Garcia-Manero, Guillermo
Zdroj: In Blood 15 November 2013 122(21):2767-2767
Databáze: ScienceDirect